- Home
- SBH vs TNGX Comparison
SBH vs TNGX Comparison
Compare SBH & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBH | TNGX |
|---|---|---|
| Founded | 1964 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | SBH | TNGX |
|---|---|---|
| Price | $15.93 | $11.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $14.83 | $12.50 |
| AVG Volume (30 Days) | 1.6M | ★ 3.3M |
| Earning Date | 02-12-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.17 | N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | ★ $3,701,424,000.00 | $66,501,000.00 |
| Revenue This Year | $2.04 | $52.80 |
| Revenue Next Year | $1.62 | N/A |
| P/E Ratio | $8.32 | ★ N/A |
| Revenue Growth | N/A | ★ 53.29 |
| 52 Week Low | $7.54 | $1.03 |
| 52 Week High | $17.40 | $12.52 |
Technical Indicators
Market Signals| Indicator | SBH | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 59.28 | 62.16 |
| Support Level | $15.42 | $9.99 |
| Resistance Level | $16.00 | $11.85 |
| Average True Range (ATR) | 0.62 | 0.93 |
| MACD | 0.13 | 0.27 |
| Stochastic Oscillator | 95.69 | 78.66 |
Price Performance
Historical ComparisonAbout SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.